Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
Cardiologist, professor and frontline doctor Peter McCullough asserts that early COVID-19 testing data indicates the genetic materials in the vaccine could be incorporated into the human genome.
VAERS data released Friday by the Centers for Disease Control and Prevention included a total of 1,103,893 reports of adverse events from all age groups following COVID vaccines, including 23,615 deaths and 188,135 serious injuries between Dec. 14, 2020, and Feb. 4, 2022.
Medical debt is the predominant cause for about 25% of consumer bankruptcies, with medical debt often triggered by "sudden adverse events — such as vaccine-induced myocarditis.